Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/Tazobactam vs Cefepime for Neutropenic Fever
NCT00044759Phase 3Completed
- Sponsor
- Pfizer
- Modality
- Irreversible Covalent Inhibitors
- Countries
- 2
01
Overview
A Phase 3 trial of piperacillin + tazobactam in febrile neutropenia (FN), sponsored by Pfizer. Status: completed.
02
Drugs
piperacillin + tazobactam
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT00044759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044759.